Publication: Both activation and inhibition of SIRT1 may act via exosomal GSK3α/β in the in vitro amyloid beta toxicity model
dc.contributor.author | Elibol, Birsen | |
dc.contributor.institutionauthor | ELİBOL, BİRSEN | |
dc.date.accessioned | 2019-12-20T20:59:12Z | |
dc.date.available | 2019-12-20T20:59:12Z | |
dc.date.issued | 2019-12-01 | |
dc.identifier.citation | Elibol B., -Both activation and inhibition of SIRT1 may act via exosomal GSK3α/β in the in vitro amyloid beta toxicity model-, Advances in Clinical Toxicology, cilt.4, no.175, ss.1-8, 2019 | |
dc.identifier.doi | 10.23880/act-16000175 | |
dc.identifier.uri | https://hdl.handle.net/20.500.12645/10643 | |
dc.language.iso | en | |
dc.title | Both activation and inhibition of SIRT1 may act via exosomal GSK3α/β in the in vitro amyloid beta toxicity model | |
dc.type | Article | |
dspace.entity.type | Publication | |
local.avesis.id | 73cea2b1-f297-4af5-b824-8a522a4d5eda | |
local.publication.isinternational | 1 | |
relation.isAuthorOfPublication | 1b1887fb-6b32-44b1-9d9f-416616dc6734 | |
relation.isAuthorOfPublication.latestForDiscovery | 1b1887fb-6b32-44b1-9d9f-416616dc6734 |